교수진 소개
- Name
- Jung Won CHUN
- Faculty Appointment:
(title, department)
- Assistant Professor
Department of Cancer Biomedical Science
- Area of Expertise
- Gastroenterology, oncology, molecular biology, translational research
- Contact no
- +82-31-920-0887
- E-mail
- deli4927@ncc.re.kr
- Work Experience
- 2022.3~current: Clinical Assistant Professor in National Cancer Center
2022.3~ current: Associate Scientist in National Cancer Center
2020.11~ 2022.2: Clinical Specialist in National Cancer Center
2019.3 ~ 2020.10: Clinical Fellowship in Seoul National University Hospital
2015.3 ~ 2019.2: Resident in Seoul National University Hospital
2014.3 ~ 2015.2: Internship in Seoul National University Hospital
- Educational Background
- 2010.3 ~ 2014.2: Seoul National University College of Medicine (Master course) (Doctor of Medicine)
2018.3 ~2023.8: Seoul National University College of Medicine Graduate School (Doctor of Philosophy)
- Research Interests
- Novel therapeutic approaches for pancreatobiliary tract cancer
Mechanistic studies of drug resistance
Clinical trials
- Achievements
-
• Annotation-Efficient Deep Learning Model for Pancreatic Cancer Diagnosis and Classification Using CT Images: A Retrospective Diagnostic Study, Cancers. 2023
• Prolonged Patency of Fully Covered Self-Expandable Metal Stent with an Externally Anchored Plastic Stent in Distal Malignant Biliary Obstruction, Endoscopy, 2023;10.1055/a-2013-2034.
• Capecitabine and Temozolomide for Metastatic Intermediate to High-Grade Pancreatic Neuroendocrine Neoplasm: A Single Center Experience, The Korean journal of internal medicine, 2022;37(6):1216-1222
• A real-world analysis of nanoliposomal-irinotecan with 5-fluorouracil and folinic acid as third- or later-line therapy in patients with metastatic pancreatic adenocarcinoma, Therapeutic advances in medical oncology, 2022
• Comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel including sequential treatment for metastatic pancreatic cancer: a propensity score matching approach, BMC cancer, 2021
• RRM1 Expression as a Prognostic Biomarker for Unresectable or Recurrent Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin, Journal of Clinical Medicine. 2021
• Comparison of liquid-based cytology with conventional smear cytology for EUS-guided FNA of solid pancreatic masses: a prospective randomized noninferiority study, Gastrointestinal Endoscopy. 2019
